|Positive WB detected in||HEK-293 cells, human placenta tissue, mouse lung tissue|
|Positive IP detected in||A549 cells|
|Positive IF detected in||HeLa cells|
|Positive FC detected in||HUVEC cells|
|Western Blot (WB)||WB : 1:500-1:1000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
13687-1-AP targets VEGFR-1/FLT-1 in WB, IP, IHC, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||Deer, human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||VEGFR-1/FLT-1 fusion protein Ag4558|
|Full Name||fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)|
|Calculated molecular weight||1338 aa, 151 kDa|
|Observed molecular weight||55-60 kDa|
|GenBank accession number||BC039007|
|Gene ID (NCBI)||2321|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Vascular endothelial growth factor receptor-1 (VEGFR-1, FLT-1) is a receptor tyrosine kinase belonging to the VEGFR family. VEGF is a key regulator of physiological angiogenesis and has also been implicated in pathological angiogenesis associated with tumors, intraocular neovascular disorders and other conditions. The biological effects of VEGF are mediated by VEGFR-1 and VEGFR-2. Both the two receptors have seven immunoglobulin-like repeats in the extracellular domain, a single transmembrane region and a tyrosine kinase domain. VEGFR-1 binds VEGFA, PIGF and VEGFB, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. Two isoforms of VEGFR-1 exist, a full-length transmembrane form and a short souble form (sVEGFR-1) consisting of only the extracellular ligand-binding domain. (PMID: 12778165; 17109193; 8806634)
|Product Specific Protocols|
|WB protocol for VEGFR-1/FLT-1 antibody 13687-1-AP||Download protocol|
|IF protocol for VEGFR-1/FLT-1 antibody 13687-1-AP||Download protocol|
|IP protocol for VEGFR-1/FLT-1 antibody 13687-1-AP||Download protocol|
|FC protocol for VEGFR-1/FLT-1 antibody 13687-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.
BMC Pregnancy Childbirth
Screening of differentially expressed proteins from syncytiotrophoblast for severe early-onset preeclampsia in women with gestational diabetes mellitus using tandem mass tag quantitative proteomics.
Int J Biochem Cell Biol
Exosomes from hypoxia-treated human adipose-derived mesenchymal stem cells enhance angiogenesis through VEGF/VEGF-R.
Int J Biol Macromol
Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2.
Cell Death Dis
Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma.
Evid Based Complement Alternat Med
The Effects of Taoren-Honghua Herb Pair on Pathological Microvessel and Angiogenesis-Associated Signaling Pathway in Mice Model of CCl4-Induced Chronic Liver Disease.